Italy: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in Italy

The Italian medicaments containing insulin market soared to $X in 2021, increasing by 134% against the previous year. Overall, consumption, however, faced a sharp setback. Over the period under review, the market hit record highs at $X in 2012; however, from 2013 to 2021, consumption stood at a somewhat lower figure.

Medicaments Containing Insulin Production in Italy

In value terms, medicaments containing insulin production totaled $X in 2021 estimated in export price. Over the period under review, production showed a noticeable downturn. The growth pace was the most rapid in 2013 with an increase of 14% against the previous year. As a result, production attained the peak level of $X. From 2014 to 2021, production growth failed to regain momentum.

Medicaments Containing Insulin Exports

Exports from Italy

Medicaments containing insulin exports from Italy shrank rapidly to X kg in 2021, with a decrease of -32% on the previous year. Overall, exports, however, posted a significant increase. The pace of growth was the most pronounced in 2020 when exports increased by 1,017% against the previous year. The exports peaked at X tons in 2014; however, from 2015 to 2021, the exports failed to regain momentum.

In value terms, medicaments containing insulin exports shrank rapidly to $X in 2021. In general, exports, however, saw significant growth. The most prominent rate of growth was recorded in 2013 with an increase of 2,970% against the previous year. As a result, the exports attained the peak of $X. From 2014 to 2021, the growth of the exports remained at a lower figure.

Exports by Country

The Czech Republic (X kg), the UK (X kg) and Germany (X kg) were the main destinations of medicaments containing insulin exports from Italy, with a combined 98% share of total exports.

From 2012 to 2021, the biggest increases were recorded for the UK (with a CAGR of +46.5%), while shipments for the other leaders experienced mixed trend patterns.

In value terms, the largest markets for medicaments containing insulin exported from Italy were the Czech Republic ($X), the UK ($X) and Germany ($X), together comprising 96% of total exports.

Among the main countries of destination, the UK, with a CAGR of +32.7%, recorded the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced mixed trend patterns.

Export Prices by Country

The average medicaments containing insulin export price stood at $X per ton in 2021, dropping by -1.7% against the previous year. In general, the export price showed a abrupt curtailment. The most prominent rate of growth was recorded in 2013 when the average export price increased by 222%. As a result, the export price attained the peak level of $X per ton. From 2014 to 2021, the average export prices remained at a lower figure.

Average prices varied somewhat for the major export markets. In 2021, amid the top suppliers, the country with the highest price was the UK ($X per ton), while the average price for exports to Germany ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to the Czech Republic (-0.9%), while the prices for the other major destinations experienced a decline.

Medicaments Containing Insulin Imports

Imports into Italy

Medicaments containing insulin imports into Italy soared to X tons in 2019, jumping by 161% against the previous year's figure. Overall, imports, however, recorded a sharp reduction. The pace of growth was the most pronounced in 2017 when imports increased by 1,037% against the previous year. Imports peaked at X tons in 2012; however, from 2013 to 2019, imports failed to regain momentum.

In value terms, medicaments containing insulin imports shrank significantly to $X in 2019. Over the period under review, imports, however, saw a sharp decrease. The smallest decline of -22.8% was in 2017. Over the period under review, imports reached the peak figure at $X in 2012; however, from 2013 to 2019, imports failed to regain momentum.

Imports by Country

In 2019, Germany (X tons) was the main medicaments containing insulin supplier to Italy, accounting for a 94% share of total imports. Moreover, medicaments containing insulin imports from Germany exceeded the figures recorded by the second-largest supplier, the Netherlands (X tons), more than tenfold.

From 2012 to 2019, the average annual growth rate of volume from Germany amounted to -41.7%. The remaining supplying countries recorded the following average annual rates of imports growth: the Netherlands (+162.1% per year) and the United States (-48.3% per year).

In value terms, Germany ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to Italy, comprising 87% of total imports. The second position in the ranking was taken by the United States ($X), with a 12% share of total imports.

From 2012 to 2019, the average annual growth rate of value from Germany stood at -44.1%. The remaining supplying countries recorded the following average annual rates of imports growth: the United States (-36.5% per year) and the Netherlands (+69.0% per year).

Import Prices by Country

In 2019, the average medicaments containing insulin import price amounted to $X per ton, declining by -89.7% against the previous year. Overall, the import price recorded a noticeable shrinkage. The most prominent rate of growth was recorded in 2018 when the average import price increased by 1,205% against the previous year. The import price peaked at $X per ton in 2015; however, from 2016 to 2019, import prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2019, amid the top importers, the country with the highest price was the United States ($X per ton), while the price for the Netherlands ($X per ton) was amongst the lowest.

From 2012 to 2019, the most notable rate of growth in terms of prices was attained by the United States (+22.8%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :